International braz j urol · 2020 · 15 citations · 15 references
MedicineOncologySurgeryGenitourinary OncologySurgical OncologyTumor PathologyBiomarkers In Genitourinary CancerGerm Cell TumorsMalignant NeoplasmsTesticular CancerTesticular DisordersTesticular PathologyLocalized Disease AssessmentPreoperative Tumor CharacterizationPrognostic Tumor MarkersSerum Tumor MarkersTesticular Cancer BiomarkersTesticular Cancer DiagnosisTumor-associated Neutrophils
PURPOSE: To assess the relationship between testicular germ cell tumors (TGCT) and neutrophil to lymphocyte ratio (NLR) and to determine whether this ratio can be used as a serum tumor marker. MATERIAL AND METHODS: Sixty-one patients with testicular germ cell tumors were included into the study. Patients were grouped as localized and non-localized. Histologically patients were categorized as seminoma and nonseminomatous germ cell tumors. Complete blood cell count was measured the day before surgery and at the postoperative 1st month. Preoperative and postoperative mean NLR values were compared. RESULTS: Thirty-six patients (59%) had seminomas and 25 patients (41%) had nonseminomatous testicular cancer. Forty-five patients (73.8%) had localized and 16 patients (26.2%) had non-localized testicular cancer. There was a statistically significant difference between preoperative and postoperative mean NLR of the localized patients (p=0.001) but no such difference was detected for non-localized patients (p=0.576). Nineteen patients with localized seminomas had normal preoperative serum tumor markers. There was a significant difference between preoperative and postoperative mean NLR in this group of patients (p=0.010). Twenty-six patients with localized tumors had preoperative increased serum tumor markers which normalized after orchiectomy. Mean NLR of these patients significantly decreased from 3.10 ± 2.13 to 1.62 ± 0.59 postoperatively (p=0.010). CONCLUSIONS: NLR appears to be a useful marker for TGCT. It is successful in predicting localized and non-localized disease in early postoperative period.
15
Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2009 · 9.7K citations · Full text
Guidelines on Testicular Cancer: 2015 Update
Peter Albers, Walter Albrecht, Ferrán Algaba et al. · European Urology · 2015 · 674 citations
Klaus‐Peter Dieckmann, Arlo Radtke, Lajos Géczi et al. · Journal of Clinical Oncology · 2019 · 343 citations · Full text
International Variations and Trends in Testicular Cancer Incidence and Mortality
Ariana Znaor, Joannie Lortet‐Tieulent, Ahmedin Jemal et al. · European Urology · 2013 · 263 citations
Medicine, Health Sciences, Oncology +13